Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.38
-3.66 (-0.40%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
85
86
Next >
A Closer Look at Eli Lilly's Options Market Dynamics
December 26, 2023
Via
Benzinga
Bristol Myers Squibb Takes On Novartis, Eli Lilly With RayzeBio $4B Deal In Radiopharmaceuticals
December 26, 2023
Bristol Myers Squibb & Co (NYSE: BMY) has agreed to acquire RayzeBio Inc (NASDAQ: RYZB) for $62.50 per share in cash, for a total equity value of approximately $4.1 billion, or $3.6 billion net of <
Via
Benzinga
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
December 25, 2023
It has genuine struggles ahead, but it has some actual value in hand as well.
Via
The Motley Fool
That's Rich
December 23, 2023
Eli Lilly is truly a force of nature. It has gone up tens of thousands of percentage points, and it’s precisely the kind of stock which, if held, can turn a middle-class family into a rich one. The...
Via
Talk Markets
7 Small-Cap Stocks That Wall Street Loves for Good Reason
December 22, 2023
The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading
Via
InvestorPlace
Can This Red-Hot Stock Beat the Market Again in 2024?
December 22, 2023
I wouldn't bet against it.
Via
The Motley Fool
How Is The Market Feeling About Eli Lilly?
December 21, 2023
Via
Benzinga
What Analysts Are Saying About Eli Lilly Stock
December 21, 2023
Via
Benzinga
What the Options Market Tells Us About Eli Lilly
December 19, 2023
Via
Benzinga
Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review
December 22, 2023
Despite a Wednesday tumble, the major indexes are right at 2023 highs.
Via
Investor's Business Daily
Looking Beyond Tech: 7 High-Growth Stocks for Substantial Returns
December 22, 2023
Place your bets on these high-growth stocks beyond tech in 2024, for a more balanced and innovative investment portfolio.
Via
InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
Opportunity is in the air with AI, and these pharma giants are seizing the moment.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ranking The Top S&P 500 Stocks By 5-Year Returns
December 21, 2023
Despite economic challenges, S&P 500 stocks have demonstrated resilience, delivering significant gains over time.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years
December 18, 2023
Via
Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
Which weight-loss stocks are good buys today?
Via
The Motley Fool
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
December 20, 2023
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's (NYSE: LLY) Zepbound and Novo Nordisk's
Via
Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n
Via
Benzinga
Exposures
COVID-19
2 Unstoppable Growth Stocks to Buy in 2024
December 20, 2023
Don't let their valuations scare you off -- these stocks still have more room to rise higher next year.
Via
The Motley Fool
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
December 20, 2023
Eli Lilly and Novo Nordisk are disrupting the weight-loss market with treatments like Mounjaro and Ozempic.
Via
The Motley Fool
3 Top Dividend Stocks That Recently Hiked Their Payouts
December 20, 2023
These stocks give investors an incentive to buy and hold.
Via
The Motley Fool
Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom
December 19, 2023
The bank predicts that by 2028, GLP-1 drugs, including Eli Lilly's Mounjaro and Zepbound, will be consumed by nearly 68 million Americans.
Via
Benzinga
Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending
December 18, 2023
Due to the recent achievements of GLP-1s, Goldman Sachs sees significant potential for Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), and other companies to venture
Via
Benzinga
Structure Stock Takes A Brutal Beating After Obesity Drug Trails Lilly's Leader
December 18, 2023
The company is hoping to break into the pack with an oral GLP-1 agonist.
Via
Investor's Business Daily
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
2024 is going to be a sizzler in the biopharma sector.
Via
The Motley Fool
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF (IBB) was down 7.5% while the S&P 500 was up more than 14%.
Via
Benzinga
Topics
ETFs
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now.
Via
InvestorPlace
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
December 16, 2023
Lilly's weight loss drug appears to be on the way to becoming a megablockbuster.
Via
The Motley Fool
Eli Lilly Dips More Than Broader Market: What You Should Know
December 16, 2023
Eli Lilly closed the latest trading day at $572.04, indicating a -0.28% change from the previous session's end. The stock's change was less than the S&P 500's daily loss of 0.01%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review
December 15, 2023
The Dow hit a record high while the S&P 500 and Nasdaq set 2023 bests.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Stocks Wall Street Bulls Are Betting On Big-Time
December 15, 2023
It’s not easy finding Wall Street’s favorite stocks. That’s because more than half the 11,062 analyst ratings are bullish.
Via
InvestorPlace
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
85
86
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.